Humana (HUM) Tops Q1 EPS by 111c; reaffirms adjusted EPS outlook

Go back to Humana (HUM) Tops Q1 EPS by 111c; reaffirms adjusted EPS outlook

Humana (HUM) PT Lowered to $353 at RBC Capital

April 25, 2024 6:44 AM EDT

RBC Capital analyst Frank Morgan lowered the price target on Humana (NYSE: HUM) to $353.00 (from $415.00) while maintaining a Outperform rating.

The analyst comments "Despite taking 2025 adjusted EPS growth targets off the table for now, management stressed its continued commitment to margin... More

Humana (HUM) PT Lowered to $360 at Cantor Fitzgerald

April 25, 2024 6:32 AM EDT

Cantor Fitzgerald analyst Sarah James lowered the price target on Humana (NYSE: HUM) to $360.00 (from $391.00) while maintaining a Neutral rating.

The analyst comments "On the positive side, HUM beat the quarter (expected by investors) and held 2024 guide (also expected by... More

Humana (HUM) surges on Q1 beat, reiterated adjusted earnings outlook

April 24, 2024 6:39 AM EDT

(Updated - April 24, 2024 6:40 AM EDT)

Shares of Humana (NYSE: HUM) jumped more than 6.5% after the company reported better-than-expected earnings and revenue for the fiscal Q1 2024.

Earnings per share (EPS) stood at $7.23 in the quarter, outperforming the consensus estimates of $6.12. Revenue came in at... More